Device type · MUJ
System, Planning, Radiation Therapy Treatment
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
MUJ
Radiology
Device class
Class II
FDA decisions since 2015
107
510(k), De Novo and PMA
Adverse event reports
17
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- System, Planning, Radiation Therapy Treatment
- Product code
- MUJ
- Device class
- Class II
- Review panel
- Radiology
- Regulation
- 21 CFR 892.5050
- Specialty
- Radiology & Imaging
- FDA record
- Classification database entry for MUJ
Latest FDA decisions
The 8 newest of 107 since 2015.
- RT Elements (4.6)510(k)
K261655 · Decided Oct 5, 2026 · 139 days after receipt
Device type: System, Planning, Radiation Therapy Treatment (MUJ) · Radiology & Imaging
- Virtual Cone (1.0)510(k)
K260750 · Decided Jul 8, 2026 · 124 days after receipt
Device type: System, Planning, Radiation Therapy Treatment (MUJ) · Radiology & Imaging
- RadOncAI510(k)
K253050 · Decided Jun 18, 2026 · 269 days after receipt
Device type: System, Planning, Radiation Therapy Treatment (MUJ) · Radiology & Imaging
104 more FDA decisions with a free account
Reports received
17
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
16
94% of reports
Injury reports
1
5.9% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 4 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 2 | 0 | 0 |
| Mar 24 | 3 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 1 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 3 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 2 | 0 | 0 | 0 |
| Feb 25 | 0 | 2 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 3 | 0 | 0 | 0 |
| May 25 | 1 | 0 | 0 | 0 |
| Jun 25 | 1 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 3 | 0 | 0 | 0 |
| Sep 25 | 2 | 0 | 0 | 0 |
| Oct 25 | 1 | 2 | 0 | 0 |
| Nov 25 | 3 | 0 | 0 | 0 |
| Dec 25 | 1 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 1 | 0 | 0 | 0 |
| May 26 | 4 | 0 | 0 | 0 |
| Jun 26 | 1 | 0 | 0 | 0 |
| Jul 26 | 1 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 3 | 0 | 0 | 0 |
| Oct 26 | 2 | 1 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
1 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Computer Software Problem13
- Insufficient Device Problem Information2
- Application Network Problem1
3 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions15
- Insufficient Information3
- Unintended Radiation Exposure1
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- RayCare 2024A SP1. Oncology Information Systems.Open, Classified
Z-2646-2026 · Started May 20, 2026 · Posted by FDA Jul 1, 2026
Reason given: Beam set delivery note issues in which there is potential data loss if the beam set delivery note is modified simultaneously and/or if a note is updated during a treatment session, the user is not notified of the change.
Cause as FDA categorized it: Under Investigation by firm
- RayCare 2024A SP4. Oncology Information Systems.Open, Classified
Z-2647-2026 · Started May 20, 2026 · Posted by FDA Jul 1, 2026
Reason given: Beam set delivery note issues in which there is potential data loss if the beam set delivery note is modified simultaneously and/or if a note is updated during a treatment session, the user is not notified of the change.
Cause as FDA categorized it: Under Investigation by firm
Z-1339-2026 · Started Dec 12, 2025 · Posted by FDA Feb 10, 2026
Reason given: Due to an error when defining a new stereotactic reference that users fail to first change an already defined obsolete reference to a pre-plan reference. This may result in a treatment plan that potentially irradiates the incorrect patient location if the error is not detected by users.
Cause as FDA categorized it: Use error
264 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.